Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,750 Cr
down ₹85.2 Cr vs Aug 2026
- Stocks held
- 31
- up 1 vs Aug 2026
- Top 10 weight
- 59.3%
- of the portfolio in its ten largest
- Cash & debt
- 6.7%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 7, trimmed 22
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In September 2026 it disclosed 31 stocks worth ₹3,750 Cr, down ₹85.2 Cr from Aug 2026. Its largest positions were IPCA Laboratories Limited (8.1%), Sun Pharmaceutical Industries Limited (7.4%), Cipla Limited (7.2%); the ten largest together made up 59.3% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 66.2% of its equity. Cash and debt stood at 6.7%. Compared with Aug 2026 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
83%
Top-10 weight is higher than 83% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
85%
Holds more cash than 85% of peers
Holdings in September 2026
Download CSVEvery line the fund disclosed, with the change against Aug 2026. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.13%
- Δ weight
- down 0.60 pts
- Value
- ₹305 Cr
- Δ value
- down ₹30 Cr
- Status
- Trimmed
- Weight
- 7.44%
- Δ weight
- down 0.51 pts
- Value
- ₹279 Cr
- Δ value
- down ₹25.8 Cr
- Status
- Trimmed
- Weight
- 7.18%
- Δ weight
- down 0.17 pts
- Value
- ₹269 Cr
- Δ value
- down ₹12.6 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 6.72%
- Δ weight
- up 3.84 pts
- Value
- ₹252 Cr
- Δ value
- up ₹142 Cr
- Status
- Added
- Weight
- 6.52%
- Δ weight
- down 0.93 pts
- Value
- ₹244 Cr
- Δ value
- down ₹41.4 Cr
- Status
- Trimmed
- Weight
- 6.15%
- Δ weight
- up 0.16 pts
- Value
- ₹231 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Held
- Weight
- 6.07%
- Δ weight
- down 0.40 pts
- Value
- ₹228 Cr
- Δ value
- down ₹20.4 Cr
- Status
- Trimmed
- Weight
- 5.15%
- Δ weight
- down 0.29 pts
- Value
- ₹193 Cr
- Δ value
- down ₹15.5 Cr
- Status
- Trimmed
- Weight
- 4.75%
- Δ weight
- up 0.66 pts
- Value
- ₹178 Cr
- Δ value
- up ₹21.3 Cr
- Status
- Added
- Weight
- 4.17%
- Δ weight
- up 0.02 pts
- Value
- ₹156 Cr
- Δ value
- down ₹3 Cr
- Status
- Trimmed
- Weight
- 3.79%
- Δ weight
- down 0.02 pts
- Value
- ₹142 Cr
- Δ value
- down ₹3.8 Cr
- Status
- Trimmed
- Weight
- 3.18%
- Δ weight
- up 0.04 pts
- Value
- ₹119 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 2.83%
- Δ weight
- up 0.03 pts
- Value
- ₹106 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 2.72%
- Δ weight
- down 0.50 pts
- Value
- ₹102 Cr
- Δ value
- down ₹21.3 Cr
- Status
- Trimmed
- Weight
- 2.70%
- Δ weight
- down 0.08 pts
- Value
- ₹101 Cr
- Δ value
- down ₹5.3 Cr
- Status
- Trimmed
- Weight
- 2.36%
- Δ weight
- down 0.03 pts
- Value
- ₹88.6 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 2.36%
- Δ weight
- down 0.08 pts
- Value
- ₹88.5 Cr
- Δ value
- down ₹5 Cr
- Status
- Trimmed
- Weight
- 2.26%
- Δ weight
- up 0.21 pts
- Value
- ₹84.9 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 1.95%
- Δ weight
- up 0.19 pts
- Value
- ₹73.3 Cr
- Δ value
- up ₹5.7 Cr
- Status
- Added
- Weight
- 1.91%
- Δ weight
- down 0.20 pts
- Value
- ₹71.6 Cr
- Δ value
- down ₹9.4 Cr
- Status
- Trimmed
- Weight
- 1.85%
- Δ weight
- down 1.85 pts
- Value
- ₹69.4 Cr
- Δ value
- down ₹72.4 Cr
- Status
- Trimmed
- Weight
- 1.64%
- Δ weight
- up 0.00 pts
- Value
- ₹61.6 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 1.35%
- Δ weight
- up 0.04 pts
- Value
- ₹50.6 Cr
- Δ value
- up ₹52 L
- Status
- Added
- Weight
- 1.12%
- Δ weight
- down 0.01 pts
- Value
- ₹41.9 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Global X Funds - Global X Genomics & Biotechnology ETFfund
- Weight
- 1.10%
- Δ weight
- up 0.12 pts
- Value
- ₹41.4 Cr
- Δ value
- up ₹3.8 Cr
- Status
- Added
- Weight
- 1.02%
- Δ weight
- up 0.04 pts
- Value
- ₹38.4 Cr
- Δ value
- up ₹56 L
- Status
- Added
- Weight
- 0.98%
- Δ weight
- up 0.06 pts
- Value
- ₹36.7 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 0.80%
- Δ weight
- down 0.07 pts
- Value
- ₹30 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 0.72%
- Δ weight
- down 0.05 pts
- Value
- ₹26.9 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Trimmed
- Weight
- 0.35%
- Δ weight
- down 0.05 pts
- Value
- ₹13.1 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 0.31%
- Δ weight
- up 0.14 pts
- Value
- ₹11.7 Cr
- Δ value
- up ₹5.1 Cr
- Status
- Added
- Weight
- 0.26%
- Δ weight
- up 0.26 pts
- Value
- ₹9.9 Cr
- Δ value
- up ₹9.9 Cr
- Status
- New
- Weight
- 0.14%
- Δ weight
- up 0.00 pts
- Value
- ₹5.4 Cr
- Δ value
- down ₹11 L
- Status
- Trimmed
What changed, Aug 2026 to Sep 2026
New New positions (1)
- Abbott India Limited0.3% · ₹9.9 Cr
Exited Exited (0)
None.
Added Biggest additions
- Alkem Laboratories Limitedup ₹21.3 Cr (+0.66% pts)
- Indoco Remedies Limitedup ₹5.9 Cr (+0.21% pts)
- Intuitive Surgical Incup ₹5.7 Cr (+0.19% pts)
- Grail Incup ₹5.1 Cr (+0.14% pts)
- Aarti Drugs Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2026, the weight rose most in Pharmaceuticals & Biotechnology (+1.0 pts) and Pharmaceuticals (+0.4 pts), and fell most in Healthcare Services (−1.7 pts).
- Pharmaceuticals & Biotechnology65.2% → 66.2%+1.0 pts
- Pharmaceuticals4.7% → 5.1%+0.4 pts
- Healthcare Equipment & Supplies7.6% → 7.9%+0.2 pts
- Healthcare Services21.3% → 19.7%−1.7 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Sep 2023 | Sep 2025 | Mar 2026 | Jun 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 73.1% | 67.7% | 64.0% | 61.5% | 65.2% | 66.2% |
| Healthcare Services | 11.7% | 17.2% | 19.3% | 23.9% | 21.3% | 19.7% |
| Healthcare Equipment & Supplies | 6.9% | 7.4% | 10.8% | 8.6% | 7.6% | 7.9% |
| Pharmaceuticals | 5.5% | 5.7% | 3.9% | 4.8% | 4.7% | 5.1% |
| Insurance | 1.9% | 1.5% | 1.5% | 1.3% | 1.0% | 1.1% |
Allocation in Sep 2026change vs Aug 2026
- Pharmaceuticals & Biotechnology (15)66.2%▲ 1.0 pts
- Healthcare Services (9)19.7%▼ 1.7 pts
- Healthcare Equipment & Supplies (3)7.9%▲ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Sep 2026
6.7%
▲ 3.8 pts vs Aug 2026
- Cash alone
- 6.7%
- cash and net receivables
- A year earlier
- 2.0%
- Sep 2025 · now ▲ 4.7 pts
- Last 12 months
- 1.0% – 6.8%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.